Impact of Virtual Reality on Pre-procedural anxieTy Prior to Heart cathEterIzAtion - VR-THEIA
NCT ID: NCT03662607
Last Updated: 2025-03-11
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
180 participants
INTERVENTIONAL
2017-04-18
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Virtual Reality Reduces Pre-Procedural Anxiety in TEER Patients, But Timing Seems Crucial
NCT07263659
Virtual Reality to Reduce Intra-procedural Anxiety and Sedation Needs During Procedures
NCT04279665
Coronary Angiography THerapeutic Virtual Reality
NCT03490903
The Effects of 360-degree Virtual Reality on Pre-procedural Anxiety in Patients Awaiting Elective Cardiac Surgery Involving a Sternotomy
NCT06001489
The Effect of Video Streaming With Virtual Reality Before Coronary Angiography
NCT06458647
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Standard pre-procedural education for cardiac catheterization.
No interventions assigned to this group
Treatment
Standard pre-procedural education plus virtual reality experience for cardiac catheterization.
Virtual reality experience
* Baseline wellness self-assessment administered (reporting on absence or presence and degree of severity of headache, nausea, dizziness, fatigue and vision abnormalities)
* Seated comfortably and free of direct obstruction
* Shown individual components of the VR system (View-Master with smartphone; headphones); given instructions; encouraged to ask questions.
* Begin the VR experience. Study personnel stay in the room \& provide guidance and answer questions regarding the technology
* When VR experience concluded, wellness self-assessment will be administered again.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Virtual reality experience
* Baseline wellness self-assessment administered (reporting on absence or presence and degree of severity of headache, nausea, dizziness, fatigue and vision abnormalities)
* Seated comfortably and free of direct obstruction
* Shown individual components of the VR system (View-Master with smartphone; headphones); given instructions; encouraged to ask questions.
* Begin the VR experience. Study personnel stay in the room \& provide guidance and answer questions regarding the technology
* When VR experience concluded, wellness self-assessment will be administered again.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18-75 years of age
* Signed study consent form
Exclusion Criteria
* History of seizures, migraine headaches or severe susceptibility to motion sickness
* Currently taking psychotropic drugs or on long-term psychotropic treatment
* Unable to read and speak English
* Visually impaired
* Unable to provide written consent
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Spectrum Health Hospitals
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ryan Madder, MD
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Spectrum Health
Grand Rapids, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-074
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.